Article
US declines to force lower price on cancer drug Xtandi
Rating:
0.0
Views:
15
Likes:
1
Library:
1
The U.S. government will not force Pfizer Inc and Astellas Pharma Inc to lower the price of their prostate cancer drug Xtandi using its emergency "march-in" authority, a federal agency said on Tuesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value